Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Sernova Biotherapeutics Inc T.SVA

Alternate Symbol(s):  SEOVF

Healthcare Biotechnology
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. The... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:SVA)

Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts

Newsfile November 13, 2025

Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang

Newsfile October 1, 2025

Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors

TheNewsWire September 23, 2025

Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference

TheNewsWire September 8, 2025

Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes

GlobeNewswire July 9, 2025

Sernova Appoints Jonathan Rigby as Interim Chair

GlobeNewswire June 2, 2025

Chair of Sernova Biotherapeutics Resigns

GlobeNewswire May 26, 2025

Sernova Biotherapeutics Appoints World-Class Clinical Advisory Board to Support Development of Cell Pouch Bio-hybrid Organ as Functional Cure for Type 1 Diabetes

GlobeNewswire May 22, 2025

Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

GlobeNewswire May 14, 2025
View More News ››

Opinion & Analysis (TSX:SVA)

Buzz on the Bullboards: 2021 The Year of the Cannabis Comeback?

Stockhouse Editorial February 11, 2021

Buzz on the Bullboards: When Stocks Go Up … Must They Come Down?

Stockhouse Editorial January 28, 2021

Buzz on the Bullboards: A Deeper Look into New Energy Opportunities

Stockhouse Editorial January 21, 2021

HemAcure and Sernova, a big deal

Richard (Rick) Mills July 25, 2017

Sernova, diabetes and haemophilia

Rick Rule July 25, 2016

Sernova (V.SVA) puts focus on diabetes treatment device

Stockhouse Editorial May 16, 2014
View More Opinion ››

Bullboard Posts (TSX:SVA)

Share price

Is anybody home?Wake me when the shareprice trades at 0.045
Dow20000 - November 13, 2025

RE:RE:RE:RE:He couldn't wait

I don't think calling someone a loser is defamatory as the world is made up of winners and losers. Just look at the share price of...
woundedknee - October 31, 2025

Conversion of debt to shares

Is there any money left in the till?This board needs to cut its overhead.They are operating on a hope and a preyer and paying people for...
Dow20000 - October 1, 2025

RE:RE:RE:He couldn't wait

Woundedknee who you calling a loser ?  The guy who is writing checks to keep Sva going ? Why dont you wait to see how the story...
MustangSalley - September 28, 2025

RE:RE:He couldn't wait

Well Steve, you are a loser. Anyway, JMO
woundedknee - September 8, 2025

RE:RE:RE:He couldn't wait

They know a guy who knows a guy.  Shhhhhh! 
rixpix - August 26, 2025
View more Bullboard ››

Sky Gold Corp.

Sky Gold Corp.

Sky Gold Corp., a junior mineral exploration company, engages in the exploration and development of mineral properties in ...
View More »